TKPRPGP is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-18. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
| Property | Value | Notes |
|---|---|---|
| Route studied | Intranasal | Predominant route in published reports |
| Circulation stability | Short, minutes scale | Peptidases cleave it; the tail slows the process |
| Analytical method | RP-HPLC with mass spectrometry | Used for identity and purity assessment |
| Reported outcome domains | Anxiety and cognitive measures | Derived from small, mostly regional trials |
| Regulatory status | Marketed in Russia | Availability outside that market is limited |
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
=== Absorption === The bioavailability of meloxicam is decreased when administered orally compared to an equivalent IV bolus dose. Different oral formulations of meloxicam are not bioequivalent. Use of oral meloxicam following a high-fat breakfast increases the mean peak drug levels by about 22%; however, the manufacturer does not make any specific meal recommendations. In addition, the use of antacids does not show pharmacokinetic interactions. With chronic dosing, the time to maximum plasma concentration following oral administration is approximately 5–6 hours.
== Early life and education == Eke was born at the University of Nigeria Teaching Hospital in Enugu State, Nigeria. He attended Federal Government College, Wukari in Taraba State, before completing his medical degree (MBChB) at the University of Calabar. He earned a Master of Public Health (MPH) from the Harvard School of Public Health, concentrating in health policy and management. He completed residency training in Obstetrics and Gynecology in Nigeria at the Nnamdi Azikiwe University Teaching Hospital, and later at Michigan State University Obstetrics and Gynecology residency training program (now University of Michigan Health - Sparrow) in the United States. He went on to complete dual fellowships in maternal-fetal medicine and clinical pharmacology at Johns Hopkins University, where he earned a doctor of philosophy (PhD) in clinical investigation through the Graduate Training Program in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health.
=== Cancer === LRP1 is involved in tumorigenesis, and is proposed to be a tumor suppressor. Notably, LRP1 functions in clearing proteases such as plasmin, urokinase-type plasminogen activator, and metalloproteinases, which contributes to prevention of cancer invasion, while its absence is linked to increased cancer invasion. However, the exact mechanisms require further study, as other studies have shown that LRP1 may also promote cancer invasion. One possible mechanism for the inhibitory function of LRP1 in cancer involves the LRP1-dependent endocytosis of 2′-hydroxycinnamaldehyde (HCA), resulting in decreased pepsin levels and, consequently, tumor progression. Alternatively, LRP1 may regulate focal adhesion disassembly of cancer cells through the ERK and JNK pathways to aid invasion. Moreover, LRP1 interacts with PAI-1 to recruit mast cells (MCs) and induce their degranulation, resulting in the release of MC mediators, activation of an inflammatory response, and development of glioma.
The first step was witnessed on live television by at least one-fifth of the population of Earth, or about 723 million people. His first words when he stepped off the LM's landing footpad were, "That's one small step for [a] man, one giant leap for mankind." Aldrin joined him on the surface almost 20 minutes later. Altogether, they spent just under two and one-quarter hours outside their craft. The next day, they performed the first crewed launch from another celestial body, and rendezvoused back with Collins in Columbia. But before they return ascended the Space Race came to a particular culmination. A few days before Apollo 11 left Earth, the Soviet Union launched the Luna 15 probe, entering lunar orbit just before Apollo 11 and eventually sharing it with Apollo 11. Aware of Luna 15, Apollo 8 astronaut Frank Borman was asked to use his goodwill contacts in the Soviet Union to prevent any collision. Subsequently, in one of the first instances of Soviet–American space communication the Soviet Union released Luna 15's flight plan to ensure it would not collide with Apollo 11, although its exact mission was not publicized. But as Apollo 11 was wrapping up surface activities, the Soviet mission command hastened Luna 15 and attempted its robotic sample-return mission before Apollo 11 would return. As Luna 15 descended just two hours before Apollo 11's launch and impacted at 15:50 UTC some hundred kilometers away from Apollo 11, British astronomers monitoring Luna 15 recorded the situation, with one commenting:"I say, this has really been drama of the highest order".
Pakistan's economy ranks 27th globally by purchasing power parity (PPP) and 42nd by nominal GDP. Historically, Pakistan was part of the wealthiest region in the first millennium CE, but lost ground to regions like China and Western Europe by the 18th century. Pakistan is a developing country, and part of the Next Eleven, poised to become one of the world's largest economies in the 21st century, alongside the BRIC countries. The semi-industrialised economy is heavily dependent on agriculture, and industrial growth in Pakistan benefits significantly from agricultural expansion. Pakistan's economy has shifted from agriculture to trade and services, with agriculture contributing about one-fifth of GDP and manufacturing one-sixth, while trade and services form the largest share. In 2023, Pakistan was the 66th-largest export economy, with a trade deficit of US$21.3 billion.
Sources: en.wikipedia.org
This distribution pattern may explain the effect they have in integral function in the control of many physiological and behavioral responses, such as feeding, anxiety, temperature regulation, locomotion, sexual behavior, and the occurrence of seizures.
=== Battle of Britain === During the battle, Chain Home stations – most notably the one at Ventnor, Isle of Wight – were attacked several times between 12 and 18 August 1940. On one occasion a section of the radar chain in Kent, including the Dover CH, was put out of action by a lucky hit on the power grid. Though the wooden huts housing the radar equipment were damaged, the towers survived owing to their open steel girder construction. Because the towers survived intact and the signals were soon restored, the Luftwaffe concluded the stations were too difficult to damage by bombing and left them alone for the remainder of the war.
The largest internationally operating media companies in Germany are Bertelsmann, Axel Springer SE and ProSiebenSat.1 Media. Germany's television market is the largest in Europe, with over 38 million TV households as of 2012. Around 90% of German households have cable or satellite TV, with a variety of free-to-view public and commercial channels. There are more than 300 public and private radio stations in Germany; Germany's national radio network is the Deutschlandradio, while the public Deutsche Welle is the main radio and television broadcaster in foreign languages. Germany's print media market is the largest in Europe. The German newspapers with the highest circulation are Bild, Süddeutsche Zeitung, Frankfurter Allgemeine Zeitung and Die Welt. The largest German magazines include ADAC Motorwelt and Der Spiegel. Germany has a large video gaming market, with over 34 million players nationwide. The annual Gamescom held in Cologne is the world's largest gaming convention. German cinema has made major technical and artistic contributions to film. The first works of the Skladanowsky Brothers were shown to an audience in 1895. The renowned Babelsberg Studio in Potsdam was established in 1912, thus being the first large-scale film studio in the world. Early German cinema was particularly influential with German expressionists such as Robert Wiene and Friedrich Wilhelm Murnau. Director Fritz Lang's Metropolis (1927) is referred to as the first major science-fiction film.
Skin cancer. The most common cause (etiology) for a nasal reconstruction is skin cancer, especially the lesions to the nose of melanoma and basal-cell carcinoma. This oncologic epidemiology occurs more readily among the aged and people who reside in very sunny geographic areas; although every type of skin is susceptible to skin cancer, white-skin is most epidemiologically prone to developing skin cancer. Furthermore, regarding plastic surgical scars, the age of the patient is a notable factor in the timely, post-surgical healing of a skin cancer defect (lesion); in terms of scarrification, the very elastic skin of young people has a greater regenerative propensity for producing scars that are thicker (stronger) and more noticeable. Therefore, in young patients, the strategic placement (hiding) of the rhinoplastic scars is a greater aesthetic consideration than in elder patients; whose less elastic skin produces scars that are narrower and less noticeable. Traumatic nasal defect. Although trauma is a less common rhinoplastic occurrence, a nasal defect or deformity caused by blunt trauma (impact), penetrating trauma (piercing), and blast trauma (blunt and penetrating) requires a surgical reconstruction that abides the conservational principles of plastic surgery, as in the corrections of cancerous lesions. Congenital deformities. The unique plastic properties of the bone, cartilage, and skin of patients' affected by congenital defects, and associated anomalies, are considered separately.
Natural fermentation predates human history. Since ancient times humans have exploited fermentation, most likely having unintentionally discovered the process. To store excess foods, humans placed the items in a container which were probably later forgotten, and over time yeast and bacteria started to grow. The earliest archaeological evidence of fermentation is the 13,000-year-old residue of beer, with the consistency of gruel, found in a cave near Haifa, Israel. Another early alcoholic drink, made from fruit, rice, and honey, dates from 7000 to 6600 BC in the Neolithic Chinese village of Jiahu. Winemaking dates from circa 6000 BC in Georgia in the Caucasus area. Seven-thousand-year-old jars containing the remains of wine, now on display at the University of Pennsylvania, were excavated in the Zagros Mountains in Iran. There is strong evidence that people were fermenting alcoholic drinks in Babylon (ca. 3000 BC), ancient Egypt (ca. 3150 BC), pre-Hispanic Mexico (ca. 2000 BC), and Sudan (ca. 1500 BC).
Sources: en.wikipedia.org
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.
Intranasal delivery is the route described in most published work. It is used because the peptide is degraded quickly once it reaches circulation. Direct evidence of brain penetration in humans is lacking.
Most trials are small, regionally concentrated, and often lack rigorous blinding or placebo control. Independent replication is limited. Reviews in English generally rate the evidence as preliminary.
Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.